<DOC>
	<DOC>NCT00237913</DOC>
	<brief_summary>Aripiprazole will show improved effectiveness over the standard of care treatment with one of three atypical antipsychotics (olanzapine, quetiapine and risperidone).</brief_summary>
	<brief_title>Schizophrenia Trial of Aripiprazole</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Clinical diagnosis of schizophrenia Schizophrenia symptoms not optimally controlled or antipsychotic medication not well tolerated Diagnosis of schizoaffective disorder Patients treatmentresistant to antipsychotics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>